glp-1 obesity drug news today september 15 2025 Retatrutide Latest Study Released:: People lost up to 85 pounds on Lilly's experimental weight loss drug, company says The results — the most weight loss ever seen in a medication trial — Eli Lilly's Obesity Pill Shows

10,36 Single-cell RNA sequencing of kidney biopsies from T2D DKD patients revealed a 1240-gene signature associated with hyperfiltration, highlighting endothelial stress and interactions between endothelial and mesangial cells

In the context of gut health, peptide bioregulators can influence epithelial integrity, support tissue regeneration, modulate immune responses, and indirectly shape the gut microbiome by creating a more balanced intestinal environment

Those include the shots Zepbound and Wegovy made by Eli Lilly and Novo Nordisk, respectively and Foundayo, Eli Lilly's answer to the Wegovy pill

Welcome to inquire